ArticleOncotarget2016

The double benefit of Spalax p53: surviving underground hypoxia while defying lung cancer cells in vitro via autophagy and caspase-dependent cell death.

Martin Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.